Zuberitamab Biosimilar - Research Grade

Human

MS4A1ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P11836

Blue ice

CD20 (MS4A1) is a B-cell surface marker and a foundational target for B-cell depletion strategies studied across oncology and autoimmunity research. This recombinant human IgG1 monoclonal is an unconjugated, non-therapeutic analog of zuberitamab directed against CD20 and is supplied for research use only (RUO). It is purified to a low-endotoxin standard suitable for in vivo studies and manufactured in scalable milligram to gram quantities for bulk and high-throughput laboratories. The antibody supports B-cell binding and depletion assays, in vitro screening, control applications, ADCC studies, and preclinical B-cell biology models.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.